GCP
GSA Capital Partners’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $395K | Sell |
9,140
-1,389
| -13% | -$60K | 0.03% | 1086 |
|
|
2025
Q1 | $364K | Buy |
+10,529
| New | +$364K | 0.03% | 1018 |
|
|
2024
Q3 | – | Sell |
-21,421
| Closed | -$543K | – | 1598 |
|
|
2024
Q2 | $543K | Buy |
+21,421
| New | +$543K | 0.04% | 910 |
|
|
2023
Q4 | – | Sell |
-86,071
| Closed | -$2.27M | – | 1505 |
|
|
2023
Q3 | $2.27M | Buy |
+86,071
| New | +$2.27M | 0.19% | 74 |
|
|
2023
Q2 | – | Sell |
-27,908
| Closed | -$463K | – | 1517 |
|
|
2023
Q1 | $463K | Sell |
27,908
-9,593
| -26% | -$159K | 0.05% | 766 |
|
|
2022
Q4 | $286K | Sell |
37,501
-6,190
| -14% | -$47.2K | 0.04% | 954 |
|
|
2022
Q3 | $434K | Sell |
43,691
-61,486
| -58% | -$611K | 0.06% | 682 |
|
|
2022
Q2 | $955K | Buy |
105,177
+70,164
| +200% | +$637K | 0.14% | 165 |
|
|
2022
Q1 | $355K | Buy |
35,013
+21,124
| +152% | +$214K | 0.05% | 774 |
|
|
2021
Q4 | $232K | Sell |
13,889
-82,107
| -86% | -$1.37M | 0.03% | 1118 |
|
|
2021
Q3 | $4.5M | Buy |
95,996
+84,749
| +754% | +$3.97M | 0.46% | 8 |
|
|
2021
Q2 | $686K | Buy |
+11,247
| New | +$686K | 0.08% | 430 |
|
|
2021
Q1 | – | Sell |
-10,385
| Closed | -$738K | – | 1101 |
|
|
2020
Q4 | $738K | Sell |
10,385
-69,505
| -87% | -$4.94M | 0.12% | 226 |
|
|
2020
Q3 | $3M | Buy |
+79,890
| New | +$3M | 0.5% | 9 |
|